DARK FOREST CAPITAL MANAGEMENT LP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
DARK FOREST CAPITAL MANAGEMENT LP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2023$62,986
+31.2%
1,400
+91.0%
0.02%
+87.5%
Q3 2022$48,000
+700.0%
733
+1283.0%
0.01%
+300.0%
Q4 2021$6,000
-97.3%
53
-97.5%
0.00%
-97.4%
Q3 2021$219,000
+995.0%
2,131
+855.6%
0.08%
+766.7%
Q2 2021$20,0002230.01%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders